FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 151 filers reported holding FATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,998 | -55.3% | 17,452 | +0.4% | 0.00% | – |
| Q2 2023 | $82,771 | -12.5% | 17,389 | +4.8% | 0.00% | – |
| Q1 2023 | $94,557 | -53.1% | 16,589 | -17.0% | 0.00% | -100.0% |
| Q4 2022 | $201,628 | -51.8% | 19,983 | +7.2% | 0.00% | -50.0% |
| Q3 2022 | $418,000 | -7.1% | 18,636 | +2.3% | 0.00% | +100.0% |
| Q2 2022 | $450,000 | -57.1% | 18,209 | -32.7% | 0.00% | -50.0% |
| Q1 2022 | $1,049,000 | -46.0% | 27,053 | -18.5% | 0.00% | -50.0% |
| Q4 2021 | $1,943,000 | +0.4% | 33,208 | +1.7% | 0.00% | -20.0% |
| Q3 2021 | $1,935,000 | -40.8% | 32,646 | -13.3% | 0.01% | -50.0% |
| Q2 2021 | $3,269,000 | +19.0% | 37,662 | +13.1% | 0.01% | +11.1% |
| Q1 2021 | $2,746,000 | +3.0% | 33,302 | +13.5% | 0.01% | -10.0% |
| Q4 2020 | $2,667,000 | +193.1% | 29,333 | +28.8% | 0.01% | +150.0% |
| Q3 2020 | $910,000 | +26.7% | 22,774 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $718,000 | +131.6% | 20,928 | +50.0% | 0.00% | +100.0% |
| Q1 2020 | $310,000 | -35.6% | 13,954 | -43.2% | 0.00% | 0.0% |
| Q4 2019 | $481,000 | +31.1% | 24,569 | +4.0% | 0.00% | 0.0% |
| Q3 2019 | $367,000 | -29.0% | 23,627 | -7.2% | 0.00% | -33.3% |
| Q2 2019 | $517,000 | +3.2% | 25,449 | -10.7% | 0.00% | 0.0% |
| Q1 2019 | $501,000 | +38.0% | 28,513 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $363,000 | – | 28,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $200,277,000 | 17.57% |
| Redmile Group, LLC | 12,957,222 | $767,975,000 | 13.39% |
| Copernicus Capital Management, LLC | 12,000 | $711,000 | 8.60% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $61,478,000 | 7.53% |
| DAFNA Capital Management LLC | 344,360 | $20,410,000 | 5.42% |
| Casdin Capital, LLC | 3,400,000 | $201,518,000 | 5.02% |
| Ally Bridge Group (NY) LLC | 270,000 | $16,003,000 | 4.70% |
| Darwin Global Management, Ltd. | 353,250 | $20,937,000 | 3.85% |
| Bellevue Group AG | 3,238,036 | $191,918,000 | 1.95% |
| Artal Group S.A. | 1,450,000 | $85,942,000 | 1.92% |